HomeGSK, Sanofi shares soar as Zantac litigation fears abateIllustration shows GSK (GlaxoSmithKline) logo

Illustration shows GSK (GlaxoSmithKline) logo

GSK (GlaxoSmithKline) logo is seen in this illustration, August 10, 2022. REUTERS/Dado Ruvic/Illustration

Zantac heartburn pills are seen in this picture illustration

Most Read

How Trump’s Pentagon pick Hegseth fell out of love with the U.S. military

November 15, 2024

Palantir shares rally to fresh record on plans for move to Nasdaq

November 15, 2024

EV companies, battery makers urge Trump not to kill vehicle tax credits

November 15, 2024

Musk expands lawsuit against OpenAI, adding Microsoft and antitrust claims

November 15, 2024